Impact of High-Pillow Sleeping Posture on Intraocular Pressure in Glaucoma
January 28, 2026
Brand Name :
Xylocaine Topical Solution, AneCream5, Derma Numb, Xylocaine Jelly, AneCream, Regenecare HA, Topicaine, Premjact, Promescent, Xolido, Solarcaine Aloe Extra Burn Relief, Lidocoll, Hawaiian Tropic Gel, LidoRx, LidoStat,
Synonyms :
lidocaine topical
Class :
Topical Anesthetics, Local Anesthetics
Brand Name :
Xylocaine Topical Solution, AneCream5, Derma Numb, Xylocaine Jelly, AneCream, Regenecare HA, Topicaine, Premjact, Promescent, Xolido, Solarcaine Aloe Extra Burn Relief, Lidocoll, Hawaiian Tropic Gel, LidoRx, LidoStat,
Synonyms :
lidocaine topical
Class :
Topical Anesthetics, Local Anesthetics
Dosage Forms & Strengths
Topical gel
0.5% (Solarcaine Aloe Extra Burn Relief)
0.8% (Hawaiian Tropic Gel)
3% (LidoRx)
4% (Topicaine)
Topical Ointment
5%
Topical spray
2% (Regenecare HA)
4% (Lidocoll, Derma Numb)
10mg/spray (Epic, Promescent,Premjact)
Topical jelly
2% (Xylocaine Jelly)
Topical cream
2% (Xolido)
4% (LidoStat, AneCream, Xolido, LMX4)
5% (AneCream5)
Topical lotion
3%
Topical solution, throat/mouth
2%
4% (Xylocaine Solution)
Dosage Forms & Strengths
Topical gel
0.5% (Solarcaine Aloe Extra Burn Relief)
0.8% (Hawaiian Tropic Gel)
3% (LidoRx)
4% (Topicaine)
Topical Ointment
5%
Topical spray
2% (Regenecare HA)
4% (Lidocoll, Derma Numb)
10mg/spray (Epic, Promescent,Premjact)
Topical jelly
2% (Xylocaine Jelly)
Topical cream
2% (Xolido)
4% (LidoStat, AneCream, Xolido, LMX4)
5% (AneCream5)
Topical lotion
3%
topical solution, throat/mouth
2%
4% (Xylocaine Solution)
Refer adult dosing
may increase the serum concentration of CYP3A4 Substrates
may have an increasingly adverse effect when combined with antiarrhythmic agents (class Ib)
may have an increasingly adverse effect when combined with antiarrhythmic agents (class Ib)
may have an increasingly adverse effect when combined with antiarrhythmic agents (class Ib)
may have an increasingly adverse effect when combined with antiarrhythmic agents (class Ib)
may have an increasingly adverse effect when combined with antiarrhythmic agents (class Ib)
lidocaine: they may enhance the serum concentration of Beta-Blockers
may enhance the serum concentration when combined with lidocaine
Actions and Spectrum:
Frequency not defined
Urticaria
Cutaneous lesions,
Anaphylactoid reactions
Edema
Hypotension
Bradycardia
Cardiovascular collapse
Central Nervous System Disorders:
Apprehension
Euphoria
Dizziness
Nervousness,
Confusion
Tinnitus
Sensations of heat, cold, or numbness
Tremors
Lightheadedness
Convulsions
Respiratory depression and arrest
Drowsiness
Blurred or double vision
Vomiting
Twitching
Unconsciousness
Black box warning:
lidocaine can cause serious side effects if misused or in excessive doses. Systemic toxicity, including seizures, respiratory depression, and cardiovascular collapse, can occur if too much lidocaine is absorbed into the bloodstream.
Contraindications/caution:
Contraindications:
lidocaine topical should not be used in individuals with known hypersensitivity or allergy to lidocaine or other local anesthetics. Additionally, it should not be applied to broken or damaged skin or mucous membranes, as this may increase the risk of systemic absorption and toxicity.
Other contraindications of lidocaine topical include:
Caution:
Pregnancy consideration: Insufficient data available
Lactation:
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacodynamics:
Pharmacokinetics:
Absorption
lidocaine topical is absorbed through the skin and into the underlying tissues. The rate and extent of absorption depend on the concentration of the medication, the area of application, and the duration of application. The onset of action for lidocaine topical is 3-5 minutes when applied as a gel, cream, or ointment.
Distribution
lidocaine is distributed throughout the body after absorption. The extent of distribution depends on various factors, including the dose, the route of administration, and the presence of tissue binding sites. lidocaine has a relatively small volume of distribution, which means it is primarily distributed in the extracellular fluid and has limited penetration into the central nervous system.
Metabolism
the liver rapidly metabolizes lidocaine into several metabolites, including MEGX and GX. These metabolites have pharmacologic activity like, but less potent than, that lidocaine. It is not known if lidocaine is metabolized in the skin.
Elimination and Excretion
The half-life of lidocaine following intravenous administration is 81-149 minutes. The total body clearance of lidocaine ranges from 0.33-0.9 L/min. lidocaine and its metabolites are primarily excreted by the kidneys, with less than 10% of the drug excreted unchanged in the urine.
Administration:
lidocaine topical is a medication applied to the skin to produce local anesthesia. It is available in various forms, including gels, creams, ointments, patches, and sprays. Here are some general guidelines for the administration of lidocaine topical:
Patient information leaflet
Generic Name: lidocaine topical
Why do we use lidocaine topical?
lidocaine topical medication produces local anesthesia or numbness in a specific body area. Here are some common uses of lidocaine topical: